Mizuhho Medy (4595) Earnings: Operating Income Decreases 32.5% YoY to 996 Million Yen, Net Income Down 19.4%

Mizuhho Medy (4595) has released its financial results, reporting net sales of 3,533 million yen (down 11.1% year-on-year), operating income of 996 million yen (down 32.5% YoY), ordinary income of 1,111 million yen (down 20.5% YoY), and net income of 822 million yen (down 19.4% YoY). The decrease in revenue and profit was mainly driven by fluctuations in demand for its mainstay infectious disease testing reagents.

Despite the softer earnings performance, the company maintains an exceptionally robust financial foundation. The equity ratio stands at a solid 88.4%, and interest-bearing debt is 0.0 billion yen, reflecting a debt-free operation. Furthermore, retained earnings have accumulated to 17.82 billion yen, demonstrating high financial resilience and safety against short-term earnings volatility. Market participants will likely continue to monitor how the company leverages its strong balance sheet for future business expansion and shareholder returns.